A rational approach to the therapy of cutaneous T-cell lymphomas;Ein rationaler Ansatz zur Therapie kutaner T-Zell-Lymphome

Onkologie

Volumn 19, Issue 3, 1996, Pages 226-230

  Dummer, R ^a,b,c   Haffner A C ^a,c   Hess, M ^a,c   Burg, G ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c NONE

Author keywords

Chemotherapy; Interferon ; Mycosis fungoides; PUVA; Radiotherapy; Retinoids; Sezary syndrome; T cell lymphomas, cutaneous

Indexed keywords

ALPHA INTERFERON; CARMUSTINE; CD4 ANTIGEN; CHLORAMBUCIL; CHLORMETHINE; INTERLEUKIN 2; METHOTREXATE; MILTEFOSINE; PREDNISONE; PSORALEN; RETINOID;

AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; MYCOSIS FUNGOIDES; PUVA; REVIEW; SEZARY SYNDROME; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0029791899     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Weinstock M, Horm J: Mycosis fungoides in the United States: Increasing incidence and descriptive epidemiology. JAMA 19S8;260:42-46.
2. Davis TH, Morton CC, Miller CR, Balk SP, Kadin ME: Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 1992326:1115-1122.
3. Burg G, Dummer R, Kerl H: Classification of cutaneous lymphomas. Dermatol Clin 1994;12:213-217.
4. Harris NL, Jaffe ES, Stein H, Banks P, Chan J, Cleary M, Delsol G, deWolf-Peeters C, Falini B, Gatter K, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Müller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994;84:1361-1392.
5. Wood GS, Tung RM, Haeffner AC, Crooks CF, Liao S, Orozco R, Veelken H, Kadin ME, Koh H, Heald P, Barnhill RL, Sklar J: Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 1994;103:34-41.
6. Burg G, Dummer R: Small plaque (digitate) parapsoriasis is an abortive T-cell lymphoma and is not mycosis fungoides. Arch Dermatol 1995;131:336-338.
7. Macaulay WL: Lymphomatoid papulosis update. A historical perspective. Arch Dermatol 19S9;125: 1387-1389.
8. Sterry W, Mielke V: CD4+ cutaneous T-cell lymphomas show the phenotype of helper/inducer T cells (CD45RA-, CDw29+). J Invest Dermatol 1989; 93:413-416.
9. Dummer R, Michie S, Kell D, Gould J, Haeffner A, Smoller B, Warnke R, Wood G: Expression of BCL-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infilitrates. J Cutan Pathol 1995:22:11-17.
10. Burg G, Braun-Falco O: Cutaneous lymphomas, pseudolymphomas and related disorders. Berlin, Springer, 1983.
11. King-Ismael D, Ackerman AB: Guttate parapsoriasis/digitate dermatosis (small plaque parapsoriasis) is mycosis fungoides. Am J Dermatopathol 1992;14: 518-530.
12. Kaye FJ, Bunn PJ, Steinberg SM, Stocker JL, Ihde DC, Fischmann AB, Glatstein EJ, Schechter GP, Phelps RM, Foss FM, Parlette HC, Anderson MJ, Sausville EA: A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 19S9;321:1784-1790.
13. Kalinke DU, Dummer R, Burg G: Management of cutaneous T-cell lymphoma. Curr Opin Dermatol 1996;3:71-76.
14. Jörg B, Kerl H, Bh T, Bröcker E-B, Burg G: Therapeutic approaches in cutaneous lymphoma. Dermatol Clin 1994;12:433-441.
15. Vonderheid EC, Tan ET, Kantor AF, Shrager L, Micaily B, Van Scott EJ: Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. J Am Acad Dermatol 19S9;20:416-428.
16. Zackheim HS, Epstein EJ, Grain WR: Topical carmustine (BCNU) for cutaneous T cell lymphoma: A 15-year experience in 143 patients J Am Acad Dermatol 1990;22:802-810.
17. Honigsmann H, Brenner W, Rauschmeier W, Konrad K, Wolff K: Photochemotherapy for cutaneous T cell lymphoma. A follow-up study. J Am Acad Dermatol 19S4;10:238-245.
18. Roenigk H, Kuzel TM, Skoutelis AP, Springer E, Yu G, Caro W, Gilyon K, Variakojis D, Kaul K, Bunn PJ: Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. J Invest Dermatol 1990;95: 198S-205S.
19. Bunn PA Jr, Morris DA: The therapeutic role of interferons and monoclonal antibodies in cutaneous T-cell lymphomas. J Invest Dermatol 1990;95: 209s-212s.
20. Dreno B, Claudy A, Meynadier J, Verret JL, Souteyrand P, Ortonne JP, Kalis B, Godefroy VY, Beerblock K, Thill L: The treatment of 45 patients with cutaneous T-cell lymphoma with low doses of interferon-alpha 2a and etretinate, Br J Dermatol 1991; 125:456-459.
21. Knobler RM, Trautinger F, Radaszkiewicz T, Kokoschka EM, Micksche M: Treatment of cutaneous T cell lymphoma with a combination of lowdose interferon alfa-2b and retinoids. J Am Acad Dermatol 1991;24:247-252.
22. Rajan G, Seifert B, Prümmer O, Joller-Jemelka H, Burg G, Dummer R: Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon-alpha2a combined with acetretin or PUVA. Arch Dermatol Res 1996,4 (in press).
23. Bauch B, Barraud-Klenowssek M, Burg G, Dummer R: Eindrucksvolle Remission einer Mycosis fungoides im Tumorstadium unter low-dose Interferon-a und Acitretin nach erfolgloser Chemotherapie. Zeitschrift H & G 1995;70:200-203.
24. Kuzel TM, Roenigk HJ, Rosen ST: Mycosis fundoides and the Sezary syndrome: a review of pathogenesis, diagnosis, and therapy. J Clin Oncol 1991; 9:1298-1313.
25. Kaplan EH, Rosen ST, Norris DB, Roenigk HH Jr, Saks SR, Bunn PA Jr: Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma. J Nail Cancer Inst 1990; 82:208-212.
26. Holloway KB, Flowers FP, Ramos CF: Therapeutic alternatives in cutaneous T-cell lymphoma. J Am Acad Dermatol 1992;27:367-378.
27. Heald P, Rook A, Ferez M, Wintroub B, Knobler R, Jegasothy B, Gasparro F, Berger C, Edelson R: Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 1992;27:427-433.
28. Bunn PJ, Hoffman SJ, Morris D, Golitz LE, Aeling JL: Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sezary syndrome). Ann Intern Med 1994;121:592-602.
29. Woodworth TG, Nichols JC: Recombinant fusion toxins - a new class of targeted biologic therapeutics. Cancer Treat Res 1993;68:145-160.
30. Dummer R, Krasovee M, Roger J, Sindermann H, Burg G: Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas: Results of a phase I/II study. J Am Acad Dermatol 199329:963-970.
31. Bigler RD, Crilley P, Micaily B, Brady LW, Topolsky D, Bulova S, Vonderheid EC, Brodsky I: Autologous bone marrow transplantation for advanced stage mycosis fungoides. Bone Marrow Transplant 1991:7:133-137.
32. Dummer R, Häffner A, Burg G: Cutaneous T-cell lymphomas (CTCL): new aspects in PCR-based diagnostic tools, immunology and treatment. Eur J Dermatol 1994;4:281-286.
33. Reinhold U, Abken H, Kukel S, Goeden B, Uerlich M, Neumann U, Kreysel HW: Tumor-infiltrating lymphocytes isolated from a Ki-1-positive large cell lymphoma of the skin. Phenotypic characterization and analysis of cytokine secretion. Cancer 1991; 68:2155-2160.
34. Dalloul A, Laroche L, Bagot M, Mossalayi MD, Fourcade C, Thacker DJ, Hogge DE, Merle BH, Debre P, Schmitt C: Interleukin-7 is a growth factor for Sezary lymphoma cells. J Clin Invest 1992; 90:1054-1060.
35. Rook AH, Kubin M, Cassin M, Vonderheid EC, Vowels BR, Wolfe JT, Wolf SF, Singh A, Trinchieri G, Lessin SR: IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. J Immunol 1995; 154:1491-1498.
36. Gisselbrecht C Maraninchi D, Pico JL, Milpied N, Coiffier B, Divine M, Tiberghien P, Bosly A, Tilly H, Boulat O, et al: Interleukin-2 treatment in lymphoma: a phase II multicenter study. Blood 1994; 83:2081-2085.
37. Burg G, Dummer R, Wilhelm M, Nestle F, Ott MM, Feller A, Hefner H, Lanz U, Schwinn A, Wiede J: A subcutaneous delta-positive T-cell lymphoma that produces Interferon gamma.' N Engl J Med 1991; 325:1078-1081.
38. Dummer R, Potoczna N, Häffner AC, Gilardi F, Zimmermann D, Burg G: A primary cutaneous non-T non-B CD4+, CD56+ lymphoma. Arch Derm 1996;5, in press.
39. Kerl H, Sterry W: Classification and staging; in Burg G, Sterry W (eds): EORTC/BMFT Cutaneous Lymphoma Project Group: Recommendations for Staging and Therapy of Cutaneous Lymphomas. 1987, pp 1-10.
40. Goldschmidt H: Radiation therapy of other cutaneous tumors; in Goldschmidl H, Panizzon R (eds): Modern Dermatologie Radiation Therapy. Berlin, Springer, 1991, pp 123-132.